These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21215624)

  • 1. Naphthalene/quinoline amides and sulfonylureas as potent and selective antagonists of the EP4 receptor.
    Burch JD; Farand J; Colucci J; Sturino C; Ducharme Y; Friesen RW; Lévesque JF; Gagné S; Wrona M; Therien AG; Mathieu MC; Denis D; Vigneault E; Xu D; Clark P; Rowland S; Han Y
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1041-6. PubMed ID: 21215624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships and pharmacokinetic parameters of quinoline acylsulfonamides as potent and selective antagonists of the EP(4) receptor.
    Burch JD; Belley M; Fortin R; Deschênes D; Girard M; Colucci J; Farand J; Therien AG; Mathieu MC; Denis D; Vigneault E; Lévesque JF; Gagné S; Wrona M; Xu D; Clark P; Rowland S; Han Y
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2048-54. PubMed ID: 18291643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discovery of novel indole-2-carboxamides as cannabinoid CB(1) receptor antagonists.
    Cowley PM; Baker J; Barn DR; Buchanan KI; Carlyle I; Clark JK; Clarkson TR; Deehan M; Edwards D; Goodwin RR; Jaap D; Kiyoi Y; Mort C; Palin R; Prosser A; Walker G; Ward N; Wishart G; Young T
    Bioorg Med Chem Lett; 2011 Jan; 21(1):497-501. PubMed ID: 21075628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of substituted-2,4-dimethyl-(naphthalene-4-carbonyl)amino-benzoic acid as potent and selective EP4 antagonists.
    Blanco MJ; Vetman T; Chandrasekhar S; Fisher MJ; Harvey A; Mudra D; Wang XS; Yu XP; Schiffler MA; Warshawsky AM
    Bioorg Med Chem Lett; 2016 Jan; 26(1):105-9. PubMed ID: 26608552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective naphthalene H(3) receptor inverse agonists with reduced potential to induce phospholipidosis and their quinoline analogs.
    Rodríguez Sarmiento RM; Nettekoven MH; Taylor S; Plancher JM; Richter H; Roche O
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4495-500. PubMed ID: 19524437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, pharmacophore modeling and in vitro activity of 10,11-dihydrodibenzo[b,f]oxepine-4-carboxamide derivatives as novel and potent antagonists of the prostaglandin EP4 receptor.
    Stasi LP; Bhimani K; Borriello M; Canciani L; Caselli G; Colace F; Ferioli C; Kaswala M; Mennuni L; Piepoli T; Pucci S; Salvi M; Shirsath V; Zanelli T; Zerbi S
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6336-40. PubMed ID: 21930381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The identification of substituted benzothiophene derivatives as PGE(2) subtype 4 receptor antagonists: From acid to non-acid.
    Li L; Mathieu MC; Denis D; Therien AG; Wang Z
    Bioorg Med Chem Lett; 2011 Jan; 21(2):734-7. PubMed ID: 21208803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel series of potent and selective EP(4) receptor ligands: facile modulation of agonism and antagonism.
    Boyd MJ; Berthelette C; Chiasson JF; Clark P; Colucci J; Denis D; Han Y; Lévesque JF; Mathieu MC; Stocco R; Therien A; Rowland S; Wrona M; Xu D
    Bioorg Med Chem Lett; 2011 Jan; 21(1):484-7. PubMed ID: 21126875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel aminothiadiazole amides as selective EP(3) receptor antagonists.
    Hilfiker MA; Wang N; Hou X; Du Z; Pullen MA; Nord M; Nagilla R; Fries HE; Wu CW; Sulpizio AC; Jaworski JP; Morrow D; Edwards RM; Jin J
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4292-5. PubMed ID: 19487124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New indole amide derivatives as potent CRTH2 receptor antagonists.
    Zaghdane H; Boyd M; Colucci J; Simard D; Berthelette C; Leblanc Y; Wang Z; Houle R; Lévesque JF; Molinaro C; Hamel M; Stocco R; Sawyer N; Sillaots S; Gervais F; Gallant M
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3471-4. PubMed ID: 21515053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent aryl-substituted 3-[(3-methylpyridine-2-carbonyl) amino]-2,4-dimethyl-benzoic acid EP4 antagonists with improved pharmacokinetic profile.
    Blanco MJ; Vetman T; Chandrasekhar S; Fisher MJ; Harvey A; Chambers M; Lin C; Mudra D; Oskins J; Wang XS; Yu XP; Warshawsky AM
    Bioorg Med Chem Lett; 2016 Feb; 26(3):931-935. PubMed ID: 26764191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Acrylamide-4-aryloxyindoles: synthesis, biological evaluation and metabolic stability of potent and selective EP3 receptor antagonists.
    Zhou N; Zeller W; Zhang J; Onua E; Kiselyov AS; Ramirez J; Palsdottir G; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1528-31. PubMed ID: 19188065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,5-Disubstituted-indole-7-carboxamides: the discovery of a novel series of potent, selective inhibitors of IKK-β.
    Miller DD; Bamborough P; Christopher JA; Baldwin IR; Champigny AC; Cutler GJ; Kerns JK; Longstaff T; Mellor GW; Morey JV; Morse MA; Nie H; Rumsey WL; Taggart JJ
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2255-8. PubMed ID: 21429745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrrolizidine esters and amides as 5-HT4 receptor agonists and antagonists.
    Becker DP; Flynn DL; Moormann AE; Nosal R; Villamil CI; Loeffler R; Gullikson GW; Moummi C; Yang DC
    J Med Chem; 2006 Feb; 49(3):1125-39. PubMed ID: 16451077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potent, highly constrained CGRP receptor antagonists.
    Stump CA; Bell IM; Bednar RA; Fay JF; Gallicchio SN; Hershey JC; Jelley R; Kreatsoulas C; Moore EL; Mosser SD; Quigley AG; Roller SA; Salvatore CA; Sharik SS; Theberge CR; Zartman CB; Kane SA; Graham SL; Selnick HG; Vacca JP; Williams TM
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2572-6. PubMed ID: 20299218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lead identification of 2-iminobenzimidazole antagonists of the chemokine receptor CXCR3.
    Hayes ME; Breinlinger EC; Wallace GA; Grongsaard P; Miao W; McPherson MJ; Stoffel RH; Green DW; Roth GP
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2414-9. PubMed ID: 18337097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.
    Yu M; Lizarzaburu M; Beckmann H; Connors R; Dai K; Haller K; Li C; Liang L; Lindstrom M; Ma J; Motani A; Wanska M; Zhang A; Li L; Medina JC
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1758-62. PubMed ID: 20137933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 4-[1-[([1-[4-(trifluoromethyl)benzyl]-1H-indol-7-yl]carbonyl)amino]cyclopropyl]benzoic acid (MF-766), a highly potent and selective EP4 antagonist for treating inflammatory pain.
    Colucci J; Boyd M; Berthelette C; Chiasson JF; Wang Z; Ducharme Y; Friesen R; Wrona M; Levesque JF; Denis D; Mathieu MC; Stocco R; Therien AG; Clarke P; Rowland S; Xu D; Han Y
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3760-3. PubMed ID: 20471829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and characterization of a potent and selective EP4 receptor antagonist.
    Schiffler MA; Chandrasekhar S; Fisher MJ; Harvey A; Kuklish SL; Wang XS; Warshawsky AM; York JS; Yu XP
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3176-8. PubMed ID: 26091726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of N-(5,6-diarylpyridin-2-yl)amide derivatives as potent and selective A(2B) adenosine receptor antagonists.
    Eastwood P; Gonzalez J; Paredes S; Nueda A; Domenech T; Alberti J; Vidal B
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1697-700. PubMed ID: 20137946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.